palliative treatment of nonresectable lung cancer by upper hemibodyperfusion of chlorimine (short-acting alkylating agent).  experiencewith five cases.a method is discussed for providing palliative treatmentfor patients with nonresectable lung cancer bymeans of administering a short-acting alkylating agentto the upper half of the body while temporarily occludingthe circulation to the lower half of the body.  with properselection of patients and an awareness of the potentialcomplications, the procedure appears to be safe and effective.